Co-founders Ellie Rubenstein and Ross Iverson discuss the added value role the firm plays for LPs and why they receive queries about their portfolio companies as soon as they close a deal.
Alexander Kalis and Brian Ruszczyk say the time is right to deploy capital in agtech and offer their view on the future of the alternative protein sector.